For laboratory research use only. Not for human or veterinary use.
PS-KLOW-2607
Analysis summary

KLOW

Sample as received: KLOW (4-peptide blend)

Reference
PS-KLOW-2607
SKU
KLOW-80MG
Presentation
Lyophilised powder
Analysis date
21 July 2026

Purity

Blend

Purity is reported individually for each declared component below. The ratio between components is determined by relative chromatographic area.

Identity

Confirmed by mass spectrometry

Method
HPLC-UV + LC-MS (ESI+)
Detection
UV 215 nm (±4 nm)

Component results

#ComponentRT / minArea %PPI %Plates NIdentity
1GHK-Cu2.51745.4598.3860Confirmed
2KPV3.47721.1899.4429Confirmed
3BPC-15710.64512.5199.91,941Confirmed
4TB-50010.90118.0799.53,508Not confirmed by MS

Area % the peak’s share of total integrated UV area. PPI % Peak Purity Index, a per-peak spectral-homogeneity measure. Plates N column efficiency.

Sample as received

Form
Lyophilised powder
Colour
Other
Condition
As expected
Peaks resolved
4

Notes

Blend certificate. Each declared component was resolved chromatographically and is reported individually; the ratio reflects relative UV area. Three of four components were additionally confirmed by mass spectrometry.

Testing

Analysed by an independent third-party analytical laboratory in the United Kingdom using established HPLC and LC-MS methods. The laboratory’s identity, the certificate it issued and its supporting records are released to verified research institutions on request.

Need the full report?

This is a summary of the analytical results. The complete analytical report — including the identity of the testing laboratory, its instrument records and the raw chromatographic data — is available to verified research institutions and qualified laboratories on request.

Request the full report